InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Robinson James A. Jr.. Director active across 2 companies, notably UroGen Pharma Ltd.. Cumulatively, 3 disclosures have been published. Activity tracked since 10 January 2026. The latest transaction was disclosed on 10 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations